NCT01436071 - Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma | Biotech Hunter

Enrollment

248

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

August 31, 2012

Conditions

Asthma

Interventions

DRUG

Fluticasone furoate 50mcg

Inhalation powder delivered by Novel Dry Powder Inhaler

DRUG

Placebo

Inhalation powder delivered by Novel Dry Powder Inhaler

Trial Locations (24)

29118

GSK Investigational Site, Orangeburg

29303

GSK Investigational Site, Spartanburg

31707

GSK Investigational Site, Albany

45040

GSK Investigational Site, Zapopan

58070

GSK Investigational Site, Morelia

65203

GSK Investigational Site, Columbia

73103

GSK Investigational Site, Oklahoma City

75110

GSK Investigational Site, Corsicana

76712

GSK Investigational Site, Waco

86100

GSK Investigational Site, Villahermosa

90025

GSK Investigational Site, Los Angeles

90808

GSK Investigational Site, Long Beach

92663

GSK Investigational Site, Newport Beach

115446

GSK Investigational Site, Moscow

141600

GSK Investigational Site, Klin

150003

GSK Investigational Site, Yaroslavl

194356

GSK Investigational Site, Saint Petersburg

394066

GSK Investigational Site, Voronezh

410028

GSK Investigational Site, Saratov

Lima 1

GSK Investigational Site, Lima

Lima 27

GSK Investigational Site, Lima

Unknown

GSK Investigational Site, Lima

Lima 41

GSK Investigational Site, San Borja

Lima 32

GSK Investigational Site, San Miguel